General Information
edit

Website	genticel.com
Category	BioTech
Employees
Description	Cervical Cancer BioPharma Company

Offices
edit

Headquarters

Pasteur-Biotop
25-28 rue du Docteur Roux
Paris , 75724, FRA

TOTAL	$41.3M
FUNDING TOTAL	$41.3M
Series C, 4/10 IDInvest Partners Amundi Private Equity Funds InnoBio Fund Edmond de Rothschild Venture Capital	$17.7M
Series D, 4/13 Wellington Partners IDInvest Partners Edmond de Rothschild Investment Partners InnoBio Fund Amundi Private Equity Funds	€18.2M

Gentiel is a clinical-stage biopharmaceutical company focused on therapeutic vaccines for the prevention of cervical cancer in HPV infected women.

Genticel received $23.6M (€18.2M) in Series D funding. (4/24/13)

Posted 4/24/13 at 4:47am via finsmes.com
Genticel received $17.7M in Series C funding. (4/5/10)

Posted 4/5/10 at 10:44pm via onbiovc.com